Retatrutide + Tirzepatide research peptide vial — Axiom
≥99% Purity
HPLC Tested
Worldwide
Hot Selling Weight Loss

Retatrutide + Tirzepatide

Dual + triple agonist blend

CODE · R+T60
From €130/ vial
Research summary

A research blend combining retatrutide and tirzepatide for metabolic pathway studies.

Key research highlights
  • Combined incretin coverage
  • Single-vial convenience
  • Advanced research

Composition & Pricing

Variant1 amp10+ amps
60mg (Reta20+Tirze40)*10vials
R+T60
130.0078.00

10+ ampules: −40% bulk discount applied automatically.

For research purposes only. Not for human consumption, diagnostic, or therapeutic use. Must be handled by qualified laboratory professionals.